Patent Assignment
Reel/Frame 063526/0959
Nunc Pro Tunc Assignment
Recorded: 2023-05-03
Pages: 6
Assignor
CELGENE CAR LLC
Executed: 2023-04-26
Assignee
BRISTOL-MYERS SQUIBB COMPANY
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NEW JERSEY, 08543
Covered Properties
(64)
2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
Heterocyclic Compounds and Uses Thereof
Heteroaryl Compounds and Uses Thereof
Mutant-Selective Egfr Inhibitors and Uses Thereof
2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
2,4-Diaminopyrimidines Useful as Kinase Inhibitors
Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
Solid Forms of an Epidermal Growth Factor Receptor Kinase Inhibitor
Salts of an Epidermal Growth Factor Receptor Kinase Inhibitor
Erk Inhibitors and Uses Thereof
Heteroaryl Compounds and Uses Thereof
2,4-Disubstituted Pyrimidines as Kinase Inhibitors
Mutant-Selective Egfr Inhibitors and Uses Thereof
2,4-Disubstituted Pyrimidine Compounds Useful as Kinase Inhibtors
Solid Forms of an Epidermal Growth Factor Receptor Kinase Inhibitor
MK2 Inhibitors and Uses Thereof
Erk Inhibitors and Uses Thereof
SUBSTITUTED PYRIDO[2,3-d]PYRIMIDINES AS PROTEIN KINASE INHIBITORS
Salts of an Epidermal Growth Factor Receptor Kinase Inhibitor
MK2 Inhibitors and Uses Thereof
Erk Inhibitors and Uses Thereof
Heteroaryl Compounds and Uses Thereof
Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
Heteroaryl Compounds and Uses Thereof
Heterocyclic Compounds and Uses Thereof
2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
Mutant-Selective Egfr Inhibitors and Uses Thereof
MK2 Inhibitors and Uses Thereof
Erk Inhibitors and Uses Thereof
Salts of an Epidermal Growth Factor Receptor Kinase Inhibitor
Solid Forms of an Epidermal Growth Factor Receptor Kinase Inhibitor
Erk Inhibitors and Uses Thereof
Forms and Compositions of an Erk Inhibitor
SUBSTITUTED PYRIDO[2,3-d]PYRIMIDINES AS INHIBITORS OF PROTEIN KINASES
Heteroaryl Compounds and Uses Thereof
Heteroaryl Compounds and Uses Thereof
MK2 Inhibitors and Uses Thereof
Patent:
10,253,040 →
Application:
15/782,995 →
Heterocyclic Compounds and Uses Thereof
Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
Forms and Compositions of an Erk Inhibitor
Salts of an Epidermal Growth Factor Receptor Kinase Inhibitor
Solid Forms of an Epidermal Growth Factor Receptor Kinase Inhibitor
2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
SUBSTITUTED PYRIDO[2,3-d]PYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
MK2 Inhibitors and Uses Thereof
Heteroaryl Compounds and Uses Thereof
MK2 Inhibitors and Uses Thereof
Heteroaryl Compounds Useful as MK2 Inhibitors
MK2 Inhibitors, Synthesis Thereof, and Intermediates Thereto
Deuterated Analogs of MK2 Inhibitors and Uses Thereof
9,10,11,12-Tetrahydro-8H-[1,4]Diazepino[5',6':4,5]Thieno[3,2-F]Quinolin-8-One Compounds and Uses Thereof
Forms and Compositions of a MK2 Inhibitor
Heterocyclic Compounds and Uses Thereof
Salts of an Epidermal Growth Factor Receptor Kinase Inhibitor
MK2 Inhibitors and Uses Thereof
2,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
Patent:
11,351,168 →
Application:
16/825,285 →
Forms and Compositions of a MK2 Inhibitor
MK2 Inhibitors, Synthesis Thereof, and Intermediates Thereto
Solid Forms of an Epidermal Growth Factor Receptor Kinase Inhibitor
Application:
17/200,019 →
Publication:
US 2022/0062280
Heterocyclic Compounds and Uses Thereof
Application:
17/445,539 →
Publication:
US 2022/0218704
Heteroaryl Compounds Useful as MK2 Inhibitors
Methods of Treating a MK2-Mediated Disorder
Application:
17/611,594 →
Publication:
US 2022/0251105
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 10, 2009
From: SINGH, JUSWINDER; PETTER, RUSSELL; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.
To: AVILA THERAPEUTICS, INC.
Reel/Frame 023213/0268 →
Assignment of Assignor's Interest
Mar 26, 2010
From: SINGH, JUSWINDER; PETTER, RUSSELL; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.
To: AVILA THERAPEUTICS, INC.
Reel/Frame 024145/0455 →
Assignment of Assignor's Interest
Dec 20, 2011
From: LEE, KWANGHO; NIU, DEQIANG; BAEVSKY, MATTHEW FRANK
To: AVILA THERAPEUTICS, INC.
Reel/Frame 027417/0952 →
Assignment of Assignor's Interest
Dec 20, 2011
From: LEE, KWANGHO; NIU, DEQIANG; PETTER, RUSSELL C.; SINGH, JUSWINDER
To: AVILA THERAPEUTICS, INC.
Reel/Frame 027417/0939 →
Assignment of Assignor's Interest
Dec 20, 2011
From: LEE, KWANGHO; NIU, DEQIANG; PETTER, RUSSELL C.; BAEVSKY, MATTHEW FRANK
To: AVILA THERAPEUTICS, INC.
Reel/Frame 027417/0924 →
Change of Name
Sep 28, 2012
From: AVILA THERAPEUTICS, INC.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 029058/0066 →
Assignment of Assignor's Interest
Jan 29, 2013
From: SINGH, JUSWINDER; PETTER, RUSSELL; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 029715/0560 →
Assignment of Assignor's Interest
Feb 1, 2013
From: SINGH, JUSWINDER; PETTER, RUSSELL C.; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 029740/0109 →
Assignment of Assignor's Interest
Feb 1, 2013
From: SINGH, JUSWINDER; PETTER, RUSSELL C.; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 029740/0146 →
Assignment of Assignor's Interest
Feb 1, 2013
From: SINGH, JUSWINDER; PETTER, RUSSELL C.; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 029740/0259 →
Assignment of Assignor's Interest
Jun 14, 2013
From: CLOVIS ONCOLOGY, INC.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 030616/0491 →
Assignment of Assignor's Interest
Jun 14, 2013
From: WITOWSKI, STEVEN RICHARD; TESTER, RICHLAND WAYNE; LEE, KWANGHO
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 030616/0792 →
Assignment of Assignor's Interest
Jun 14, 2013
From: LAI, MEI
To: CLOVIS ONCOLOGY, INC.
Reel/Frame 030616/0754 →
Assignment of Assignor's Interest
Jun 14, 2013
From: LAI, MEI
To: CLOVIS ONCOLOGY, INC.
Reel/Frame 030616/0450 →
Assignment of Assignor's Interest
Jun 18, 2013
From: CLOVIS ONCOLOGY, INC.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 030637/0075 →
Assignment of Assignor's Interest
Mar 6, 2014
From: HAQ, NADIA; NIU, DEQIANG; PETTER, RUSSELL C.; QIAO, LIXIN
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 032363/0253 →
Assignment of Assignor's Interest
May 7, 2014
From: SINGH, JUSWINDER; PETTER, RUSSELL; TESTER, RICHLAND WAYNE; KLUGE, ARTHUR F.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 032840/0233 →
Assignment of Assignor's Interest
Oct 10, 2014
From: SINGH, JUSWINDER
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 033927/0162 →
Assignment of Assignor's Interest
Oct 10, 2014
From: D'AGOSTINO, LAURA AKULLIAN; SJIN, ROBERT TJIN THAM; NIU, DEQIANG; MCDONALD, JOSEPH JOHN
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 033927/0167 →
Assignment of Assignor's Interest
Nov 18, 2014
From: BARRAGUE, MATTHIEU; GROSS, ALEXANDRE; MUNSON, MARK
To: SANOFI
Reel/Frame 034196/0253 →
Assignment of Assignor's Interest
Sep 9, 2015
From: CLOVIS ONCOLOGY, INC.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 036522/0091 →
Assignment of Assignor's Interest
Sep 9, 2015
From: LAI, MEI
To: CLOVIS ONCOLOGY, INC.
Reel/Frame 036522/0032 →
Assignment of Assignor's Interest
Mar 2, 2016
From: LEE, KWANGHO; SINGH, JUSWINDER; NIU, DEQIANG; PETTER, RUSSELL C.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 037873/0470 →
Assignment of Assignor's Interest
Apr 12, 2016
From: LEE, KWANGHO; NIU, DEQIANG; BAEVSKY, MATTHEW F.
To: CELGENE AVILOMICS RESEARCH, INC.
Reel/Frame 038249/0775 →
Merger and Change of Name
Feb 16, 2017
From: CELGENE AVILOMICS RESEARCH, INC.; CELGENE CAR LLC
To: CELGENE CAR LLC
Reel/Frame 041738/0041 →